A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2004
11/25/2004	WO2003096972A3 Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof
11/25/2004	WO2003092594A8 Adeno-associated viral vectors and methods for their production from hybrid adenovirus and for their use
11/25/2004	WO2003090599A3 Methods and apparatus for modifying properties of the bbb and cerebral circulation by using the neuroexcitatory and/or neuroinhibitory effects of odorants on nerves in the head
11/25/2004	WO2003086280A3 Immunostimulatory g,u-containing oligoribonucleotides
11/25/2004	WO2003082924A8 Immunotherapeutic and immunoprophylactic reagents
11/25/2004	WO2003082906A3 Neurotrophic and neuroprotective peptides
11/25/2004	WO2003078648A3 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis
11/25/2004	WO2003078578A3 Modulation of the immune response through the manipulation of arginine levels
11/25/2004	WO2003070906A3 Cellular genes regulated by hiv-1 infection and methods of use thereof
11/25/2004	WO2003070892A3 Inhibitors of rgs proteins
11/25/2004	WO2003070197A3 RNA INTERFERENCE MEDIATED INHIBITION OF TGF-BETA AND TGF-BETA RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/25/2004	WO2003038047A3 Human telomerase reverse transcriptase as a class-ii restricted tumor-associated antigen
11/25/2004	WO2003000006A3 Stackable low depth tray
11/25/2004	WO2002078524A3 Translational profiling
11/25/2004	US20040237127 Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation
11/25/2004	US20040236092 Peptidologlycan recognition protein encoding nucleic acids and methods of use thereof
11/25/2004	US20040236091 Nucleotide sequences coding major histocompatibility complex proteins for use in diagnosis, prevention and treatment of cell proliferative disorders
11/25/2004	US20040236088 Nucleotide sequences coding transmembrane protein for use in generating monoclonal antibodies for treatment and prevention of diabetes, allergies, autoimmune, inflammatory, cell proliferative and infectious diseases
11/25/2004	US20040236081 Immunoglobulin which binds interleukkin-1bconverting enzyme for use in diagnosis, treatment and prevention of autoimmune, neurodegenerative and cell proliferative disorders
11/25/2004	US20040236078 Binds p185HER2 and has a framework region (FR) substitution at a VH71, VH73, VH78, VH93, or VL66 FR position; has the low immunogenicity of huMAb4D5-8 upon repeated administration to treat breast cancer
11/25/2004	US20040236073 A polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor
11/25/2004	US20040236071 Alzheimer's disease
11/25/2004	US20040235962 Conformationally restricted polyamine analogs as disease therapies
11/25/2004	US20040235953 Administering nitric oxide precursor selected from citrulline, arginine to prevent hepatitis, cirrhosis, pulmonary hypertension, necrotizing enterocolitis (NEC), acute respiratory distress syndrome, erectile dysfunction and bone marrow transplant toxicity
11/25/2004	US20040235804 Multiple dose aromatase inhibitor for treating infertility
11/25/2004	US20040235794 Remedies for respiratory diseases comprising sphingosine-1-phosphate receptor controller
11/25/2004	US20040235785 Potentiator of antitumoral agents in the treatment of cancer
11/25/2004	US20040235776 Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancer
11/25/2004	US20040235769 Anti-tumor effects of prostage Carcinoma Tumor Antigen-1
11/25/2004	US20040235767 Synergistic mixture comprises cell adhesion molecule or a mammalian expression vector containing DNA; gene therapy; antitumor agents
11/25/2004	US20040235764 Methods of inhibiting expression of a target gene in mammalian cells
11/25/2004	US20040235754 Dipeptide derivatives
11/25/2004	US20040235751 Reduction of zinc-induced neurotoxic injury by blockade of nitric oxide synthesis
11/25/2004	US20040235749 Administering peptide or peptidomimetic compound; culturing cells; measuring cell calcium, phosphoinositide hydrolysis, increased/decreased cellular cyclic adenosine monophosphate, cell growth and/or differentiation, altered gene expression, and smooth contraction or dilation
11/25/2004	US20040235748 Agents for preventing postoperative recurrence of premenopausal breast cancer
11/25/2004	US20040235747 Administering Activity Dependent Neurotrophic Factor (ADNF) polypeptide as neuroprotective agent; multiple sclerosis
11/25/2004	US20040235746 Cell permeable peptides for inhibition of inflammatory reactions and methods of use
11/25/2004	US20040235745 Basic polypeptide against Grampositive and Gramnegative bacteria; noncytoxic
11/25/2004	US20040235744 Purified nitric oxide synthase
11/25/2004	US20040235743 Soluble zalpha11 cytokine receptors
11/25/2004	US20040235741 Human papilloma virus treatment
11/25/2004	US20040235740 Administered as antitumor, antimetastasis, anticarcinogenic and/or wound healing agent; tissue regeneration
11/25/2004	US20040235738 Novel antimicrobial peptide isolated from penaeus monodon
11/25/2004	US20040235737 A mixture of blood-coagulation factor IX and antihemophilic factor to treat hemophilia and blood disorders in patient not presenting with anti-FVIII antibodies
11/25/2004	US20040235736 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
11/25/2004	US20040235735 Gene expression of cells; genetic engineering using tripeptides; antiinflammatory agents; apoptosis;medical diagnosis
11/25/2004	US20040235733 Methods and reagents for reducing polyglutamine toxicity
11/25/2004	US20040235732 Method for modulating angiogenesis using prokineticin receptor antagonists
11/25/2004	US20040235731 package contains low molecular weight peptide-based thrombin inhibitors (melagatran), sealed with rubber stopper/plunger
11/25/2004	US20040235730 Non-naturally occurring lipoprotein particle
11/25/2004	US20040235729 Complementarity-determining region; monoclonal antibodies; antiidiotypic antibodies; autoantibodies; heavy chains; light chains; polypeptides; amino acid sequences; DNA; carriers; use for treatment of systemic lupus erythematosus in humans
11/25/2004	US20040235728 Compositions and methods for treating osteoporosis
11/25/2004	US20040235726 Glucagon-like peptides (glp-1) and treatment of respiratory distress
11/25/2004	US20040235724 Use of specific inhibitors of metalloproteinases (so-called "tissue inhibitor of metalloproteinases 1") for production of a composition for treatment of diseases characterised by increased immunological activity such as multiple sclerosis, Crohn's disease, graft-versus-host disease, autoimmune diseases
11/25/2004	US20040235722 Assay that makes use of the interaction of early pregnancy factor (EPF) or an EPF-related peptide with a human dorsal root receptor (hDRR) or hDRR related receptor; also useful to determine whether the test compound is an agonist or antagonist of hDRRs
11/25/2004	US20040235721 Relates to polynucleotides coding for PPVO viral genome, to fragments of polynucleotides coding for PPVO genome and to polynucleotides coding for individual open reading frames of PPVO viral genome; for treatment of viral, non-viral infections, proliferative, inflammatory, autoimmune diseases
11/25/2004	US20040235720 May also be used in combination with an interferon for treatment and/or prevention of diseases such as traumatic nerve injury, stroke, demyelinating diseases of the CNS or PNS, neuropathies and neurodegenerative diseases
11/25/2004	US20040235719 Reacting a first aliquot of the protein with a heterobifunctional coupling agent; and reacting the product with a second aliquot of the protein wherein the coupling reagent contains groups reactive to thiol groups and groups reactive to amine groups
11/25/2004	US20040235718 Use of Afamin, in particular in combination with vitamin E, is for treatment of oxidative stress; treatment of Alzheimer's Disease, Huntington's Disease or amyotropic lateral sclerosis
11/25/2004	US20040235716 Novel cyclosporins
11/25/2004	US20040235714 Nucleic acid molecule comprising sequence which encodes a neurotrophic factor receptor protein capable of complexing with glial cell line-derived neurotrophic factor or neurturin neurotrophic factor thereby mediating cell response to said neurotrophic factor; treatment of Parkinson's, Alzheimer's disease
11/25/2004	US20040235711 Immunopotentiator for mammary gland of dairy cows containing lactoferrin as an active ingredient
11/25/2004	US20040235710 Comprising a GLP-1 compound and an acylated basal insulin or a pI shifted basal insulin; can be used to treat diseases such as non-insulin dependent diabetes mellitus and insulin dependent diabetes mellitus, hyperglycemia, obesity
11/25/2004	US20040235709 Gssp3 polynucleotides and polypeptides and uses thereof
11/25/2004	US20040235171 Using post-transcriptional silencing to treat cell proliferative disorders associated with human papiloma viral infection; RNA interference; antitumor/antiviral agents
11/25/2004	US20040235164 Antisense nucleotide sequences for use in the prevention and treatment of asthmatic disorders; gene expression ihibition
11/25/2004	US20040235137 Novel lanthionine antibiotic compositions and methods
11/25/2004	US20040235136 Novel protein molecule useful for inhibition of anthrax toxin
11/25/2004	US20040235129 KDEL receptor inhibitors
11/25/2004	US20040235117 Fusion protein comprised of t umor necrosis factor, cartilage oligomeric and cartliage matrix protein domains for use in identifying modulator for treatment of infections, autoimmue, cell proliferative, neurodegenerative and inflammatory diseases
11/25/2004	US20040235116 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
11/25/2004	US20040235113 18 human secreted proteins
11/25/2004	US20040235112 Enzymatic polypeptide for use in detection of modulators for prevention a nd treatment of inflammatory, cell proliferative and autoimmune diseases; enzyme inhibitors
11/25/2004	US20040235110 Immunoglobulin for use in identifying polypeptides which inhibit cell proliferation; immunoassay; immunodiagnostics
11/25/2004	US20040235106 18891, a novel human lipase
11/25/2004	US20040235104 Nucleotide sequences coding similar expression of fibroblast growth factors genes (SEF) for use as tools in identifying modulators of cardiovascular, urogenital and cell proliferative disorders
11/25/2004	US20040235097 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
11/25/2004	US20040235095 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
11/25/2004	US20040235094 Regulation of human ptpase-like protein
11/25/2004	US20040235093 Isolated human transporter proteins nucleic acid molecules encoding human transporter proteins and uses thereof
11/25/2004	US20040235092 Comprises expression vectors coding heterologous protein for use as tools in diagnosis and treatment of cell proliferative, nervous system, inflammatory and autoimmune diseases
11/25/2004	US20040235091 Preparing protease resistant, bioactive amino acid sequences for use as therapeutic peptides; biodrugs; mimetics
11/25/2004	US20040235083 Screening method
11/25/2004	US20040235079 Identifying modulators associated with heme independent inhibition of soluble guanylyl cyclase for use in treatment of infection, hypertension and cardiovascular disorders
11/25/2004	US20040235074 Methods for the treatment or prevention of immune disorders using anti-CD40 antibodies
11/25/2004	US20040235073 Using nuclear and lower cytosolic localization of kruppel-like transcription factors to diagnose and prognose viability of individuals with cell proliferative disorders
11/25/2004	US20040235072 Compositions and methods for the therapy and diagnosis of lung cancer
11/25/2004	US20040235071 Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 21617, 39228, 49928, 54476, 62113, 64316, 12264, 32362, 58198, 2887, 3205, 8557, 9600, 9693, 44867, 53058, 55556, 57658, 2208, 10252, 10302, 14218, 33877, 10317, 10485, 25964, 14815, 1363, 1397, 14827, 21708, 3801, 64698, 2179 or 13249
11/25/2004	US20040235066 Using immunoglobulin specific to cancer testis-antigens for use in diagnosis and treatment of cell proliferative diseaes; immunotherapy
11/25/2004	US20040235058 ULBP antibodies
11/25/2004	US20040235057 Monoclonal antibody which recognizes polypeptide comprising heme binding motif and sequencially related to cytochrome p450 for use in preventing hydroxylation of retinoic acid and treating cell proliferative and skin disorders
11/25/2004	US20040235047 Therapeutic agent comprising cytokine inhibitory activity for use in treatment of respiratory system disorders; viricides; antisense agents; enzyme inhibitors; immunotherapy; RNA interference; recombinant cytokine receptors
11/25/2004	US20040235041 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
11/25/2004	US20040235031 Using catalytic, self-cleaving RNA species to cleave connective tissue growth factor (CTGF) and decrease scarring during healing; wound healing agent
11/25/2004	US20040235020 Methods for monitoring drug activities in vivo
11/25/2004	US20040235017 Comprises nucleotide sequences coding cyclooxygenase for use in identifying pain preventative and antiinflammatory agents; more specific cyclooxygenases reduced side effects
11/25/2004	US20040234999 Biopolymer mixtures for use in the inhibition of gene expression; RNA interference and gene therapy
11/25/2004	US20040234993 Comprises nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of asthma, chronic obstructive pulmonary disease (COPD) and arthritis
11/25/2004	US20040234990 Method of screening alzheimer's disease-associated gene
11/25/2004	US20040234982 Human ugrp (uteroglobin-related protein) 1 promoter and its use

1 ... 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 ... 3163